FFCP PHASE1:Hg19::chr6:42724431..42724435,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport= | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=not | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C412 | |||
|description=CAGE_peak_at_chr6:42724431..42724435,+ | |||
|id=chr6:42724431..42724435,+ | |||
|ontology_enrichment_celltype=CL:0002149!5.98e-34!6;CL:0002255!5.98e-34!6;CL:0000499!1.98e-08!27 | |||
|ontology_enrichment_celltype_v019=CL:0002149;9.76e-45;6!CL:0002255;9.76e-45;6!CL:0000499;1.40e-10;28 | |||
|ontology_enrichment_celltype_v019_2=CL:0002149,9.76e-45,6;CL:0002255,9.76e-45,6;CL:0000499,1.40e-10,28;CL:0002076,2.04e-07,42 | |||
|ontology_enrichment_development_v019=UBERON:0005795;2.08e-27;10 | |||
|ontology_enrichment_disease=DOID:3001!5.98e-34!6;DOID:120!2.09e-17!27;DOID:193!2.82e-16!29;DOID:299!5.06e-09!25 | |||
|ontology_enrichment_disease_v019=DOID:3001;9.76e-45;6!DOID:120;5.98e-23;27!DOID:193;1.88e-21;29!DOID:299;1.03e-11;25 | |||
|ontology_enrichment_disease_v019_2=DOID:3001,9.76e-45,6;DOID:120,5.98e-23,27;DOID:193,1.88e-21,29;DOID:299,1.03e-11,25 | |||
|ontology_enrichment_uberon=UBERON:0002110!1.12e-17!3;UBERON:0006242!1.12e-17!3;UBERON:0003134!5.74e-13!37;UBERON:0000474!5.74e-13!37;UBERON:0003100!8.57e-12!41;UBERON:0002118!3.26e-11!5;UBERON:0004532!3.26e-11!5;UBERON:0000995!1.53e-10!21;UBERON:0003133!3.32e-10!48;UBERON:0005795!4.14e-10!22;UBERON:0003975!4.14e-10!22;UBERON:0004175!5.06e-09!25;UBERON:0005156!1.83e-08!59;UBERON:0000990!1.83e-08!59;UBERON:0002294!2.35e-08!7;UBERON:0001173!2.35e-08!7;UBERON:0004912!2.35e-08!7 | |||
|ontology_enrichment_uberon_v019=UBERON:0003134;8.88e-21;33!UBERON:0000995;1.17e-16;17!UBERON:0003975;8.40e-16;18!UBERON:0000474;1.52e-15;37!UBERON:0002118;1.83e-14;5!UBERON:0004175;1.02e-13;21!UBERON:0003100;1.29e-13;41!UBERON:0003133;8.61e-11;44!UBERON:0005156;1.41e-10;59!UBERON:0000990;1.41e-10;59 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0003134,4.49e-17,37;UBERON:0000474,4.49e-17,37;UBERON:0003100,1.60e-15,41;UBERON:0002118,1.83e-14,5;UBERON:0000995,1.02e-13,21;UBERON:0003133,2.00e-13,48;UBERON:0005795,3.77e-13,22;UBERON:0003975,3.77e-13,22;UBERON:0004175,1.03e-11,25;UBERON:0005156,3.99e-11,59;UBERON:0000990,3.99e-11,59 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.213452994739353,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.32016879939247,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.2368107269226,8.5998504507969,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr6:42724431..42724435,+ | |||
}} |
Revision as of 11:56, 22 January 2014
Short description: | p@chr6:42724431..42724435, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | No |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr6:42724431..42724435, + |
Coexpression cluster: | C412_serous_breast_papillotubular_ductus_seminal_kidney_clear |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
epithelial cell of uterus | 9.76e-45 | 6 |
stromal cell of endometrium | 9.76e-45 | 6 |
stromal cell | 1.40e-10 | 28 |
endo-epithelial cell | 2.04e-07 | 42 |
Ontology term | p-value | n |
---|---|---|
female reproductive organ | 4.49e-17 | 37 |
female reproductive system | 4.49e-17 | 37 |
female organism | 1.60e-15 | 41 |
right ovary | 1.83e-14 | 5 |
uterus | 1.02e-13 | 21 |
reproductive organ | 2.00e-13 | 48 |
embryonic uterus | 3.77e-13 | 22 |
internal female genitalia | 3.77e-13 | 22 |
internal genitalia | 1.03e-11 | 25 |
reproductive structure | 3.99e-11 | 59 |
reproductive system | 3.99e-11 | 59 |
Ontology term | p-value | n |
---|---|---|
female reproductive endometrioid cancer | 9.76e-45 | 6 |
female reproductive organ cancer | 5.98e-23 | 27 |
reproductive organ cancer | 1.88e-21 | 29 |
adenocarcinoma | 1.03e-11 | 25 |